Top

International Journal of Behavioral Medicine

Published in:

01-02-2018

Cognitive and Perceptual Factors, Not Disease Severity, Are Linked with Anxiety in COPD: Results from a Cross-Sectional Study

Authors: Elyse R. Thakur, Shubhada Sansgiry, Nancy J. Petersen, Melinda Stanley, Mark E. Kunik, Aanand D. Naik, Jeffrey A. Cully

Published in: International Journal of Behavioral Medicine | Issue 1/2018

Abstract

Purpose

Guided by the Transactional Model of Stress and Coping, the purpose of this cross-sectional study was to examine clinical factors—demographics, chronic obstructive pulmonary disease (COPD) severity, cognitive/perceptual variables (appraisal and coping)—and their relationship to clinically elevated symptoms of anxiety in a sample of veterans with COPD.

Method

Participants included a sample of veterans with COPD, with or without comorbid congestive heart failure, and clinically significant symptoms of anxiety (n = 172, mean age = 65.3, SD = 8.1), who previously presented to an outpatient VA setting. Participants completed questionnaires examining COPD severity (respiratory impairment and dyspnea- and fatigue-related quality of life); perceptions of a stressor (COPD illness intrusiveness); perceptions of control (locus of health control, mastery over COPD, self-efficacy); coping strategies (adaptive and maladaptive); and anxiety and depressive symptoms.

Results

Multivariable linear regressions revealed that anxiety was positively associated with more maladaptive coping and locus of control (attributed to other people), above and beyond disease severity, demographics, and depressive symptoms.

Conclusion

These findings suggest that cognitive and perceptual factors are concurrent with anxiety; however, longitudinal investigations are needed to fully understand this relationship. Future research should also focus on identifying optimal assessment and treatment procedures when evaluating and treating patients with COPD and symptoms of anxiety.

Trial Registration

NCT01149772

Buist AS, MA MB, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–50.CrossRefPubMed

Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294(10):1255–9.CrossRefPubMed

Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–9.CrossRefPubMedPubMedCentral

Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613–20.CrossRefPubMed

Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and reatment. Psychosom Med. 2003;65(6):963–70.CrossRefPubMed

Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–11.PubMed

Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209–21.CrossRefPubMed

Aydin IO, Uluşahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry. 2001;23(2):77–83.CrossRefPubMed

Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD. Current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–56S.CrossRefPubMedCentral

10.

Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–9.CrossRefPubMed

11.

Yellowlees PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE. Psychiatric morbidity in patients with chronic airflow obstruction. Med JAust. 1987;46(6):305–7.

12.

Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in chronic obstructive pulmonary disease (COPD). A review Nord J Psychiatry. 2004;58(1):65–70.CrossRefPubMed

13.

Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006;47(4):312–9.CrossRefPubMed

14.

Meek PM, Lareau SC. Critical outcomes in pulmonary rehabilitation: assessment and evaluation of dyspnea and fatigue. J Rehabil Res Dev. 2003;40(5 Suppl 2):13–24.CrossRefPubMed

15.

Harver A, Mahler DA. Dyspnea: sensation, symptom, and illness. Lung Biol Health Dis. 1998;111:1–33.

16.

Felker B, Bush KR, Harel O, Shofer JB, Shores MM, Au DH. Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease. Prim Care Companion J Clin Psychiatry. 2010;12(4).

17.

Coultas DB, Edwards DW, Barnett B, Wludyka P. Predictors of depressive symptoms in patients with COPD and health impact. COPD. 2007;4(1):23–8.CrossRefPubMed

18.

Paukert AL, Lemaire A, Cully JA. Predictors of depressive symptoms in older veterans with heart failure. Aging Ment Health. 2009;13(4):601–10.CrossRefPubMed

19.

Devins GM, Bezjak A, Mah K, Loblaw DA, Gotowiec AP. Context moderates illness-induced lifestyle disruptions across life domains: a test of the illness intrusiveness theoretical framework in six common cancers. Psyco-Oncology. 2006;15(3):221–33.CrossRef

20.

Shuster J, McCormack J, Riddell RP, Toplak ME. Understanding the psychosocial profile of women with fibromyalgia syndrome. Pain Res Manag. 2009;14(3):239–45.CrossRefPubMedPubMedCentral

21.

Wallston KA, Wallston BS, Smith S, Dobbins CJ. Perceived control and health. Curr Psychol: Res Rev. 1987;6:5–25.CrossRef

22.

Edwards R, Telfair J, Cecil H, Lenoci J. Self-efficacy as a predictor of adult adjustment to sickle cell disease: one-year outcomes. Psychosom Med. 2001;63(5):850–8.CrossRefPubMed

23.

Lee H, Young Yoon J, Kim I, Young-Hee J. The effects of personal resources and coping strategies on depression and anxiety in patients with chronic obstructive pulmonary disease. Heart Lung. 2013;42(6):473–9.CrossRefPubMed

24.

Simpson E, Jones MC. An exploration of self-efficacy and self-management in COPD patients. Br J Nurs. 2013;22(19):1105–9.CrossRefPubMed

25.

Breland JY, Hundt NE, Barrera TL, Mignogna J, Petersen NJ, Stanley MA, et al. Identification of anxiety symptom clusters in patients with COPD: implications for assessment and treatment. Int J Behav Med. 2015;22(5):1–7.CrossRef

26.

Scharloo M, Kaptein AA, Weinman JA, Willems LNA, Rooijmans HGM. Physical and psychological correlates of functioning in patients with chronic obstructive pulmonary disease. J Asthma. 2000;37(1):17–29.CrossRefPubMed

27.

Stoilkova A, Janssen DJ, Franssen FM, Spruit MA, Wouters EF. Coping styles in patients with COPD before and after pulmonary rehabilitation. Respir Med. 2013;107(6):825–33.CrossRefPubMed

28.

McCathie HCF, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J. 2002;19(1):47–53.CrossRefPubMed

29.

Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer; 1984.

30.

Englbrecht M, Gossec L, DeLongis A, Scholte-Voshaar M, Sokka T, Kvien TK, et al. The impact of coping strategies on mental and physical well-being in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2012;41(14):545–55.CrossRefPubMed

31.

Cully JA, Armento ME, Mott J, Nadorff MR, Naik AD, Stanley MA, et al. Brief cognitive behavioral therapy in primary care: a hybrid type 2 patient-randomized effectiveness implementation design. Implement Sci. 2012;7:64.CrossRefPubMedPubMedCentral

32.

Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6.CrossRefPubMedPubMedCentral

33.

Spitzer RL, Williams JB, Kroenke K, Linzer M, de Gruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272(22):1749–56.CrossRefPubMed

34.

Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773–8.CrossRefPubMedPubMedCentral

35.

Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttmann RD. The emotional impact of end-stage renal disease: importance of patients’ perceptions of intrusiveness and control. Int J Psychiatry Med. 1983;13(4):327–43.CrossRefPubMed

36.

Wallston KA, Stein MJ, Smith CA. Form C of the MHLC scales: a condition-specific measure of locus of control. J Pers Assess. 1994;63(3):534–53.CrossRefPubMed

37.

Lorig K, Stewart A, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcome measures for health education and other health care interventions. Thousand Oaks: Sage Publications; 1996.

38.

Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92–100.CrossRefPubMed

39.

Beck A, Steer R. Beck anxiety inventory manual. San Antonio: Harcourt Brace and Company; 1990.

40.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefPubMedPubMedCentral

41.

Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med. 2006;119(10 Suppl 1):12–20.CrossRefPubMed

42.

Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006;119(10 Suppl 1):32–7.CrossRefPubMed

43.

Bendel RB, Afifi A. Comparison of stopping rules in forward regression. J Am Stat Assoc. 1977;72:46–53.

44.

Hundt NE, Amspoker AB, Kraus-Schuman C, Cully JA, Rhoades H, Kunik ME, et al. Predictors of CBt outcome in older adults with GAD. J Anxiety Disord. 2014;28(8):845–50.CrossRefPubMedPubMedCentral

45.

Barrera TL, Cully JA, Amspoker AB, Wilson NL, Kraus-Schuman C, Wagener PD, et al. Cognitive-behavioral therapy for late-life anxiety: similarities and differences between veteran and community participants. J Anxiety Disord. 2015;33:72–80.CrossRefPubMedPubMedCentral

46.

Asadi-Pooyab AA, Schilling CA, Glosser D, Tracy JI, Sperling MR. Health locus of control in patients with epilepsy and its relationship to anxiety, depression, and seizure control. Epilepsy Behav. 2007;11(3):347–50.CrossRef

47.

Carver CS, Connor-Smith J. Personality and coping. Annu Rev Psychol. 2010;61:679–704.CrossRefPubMed

48.

Van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54(8):688–92.CrossRefPubMedPubMedCentral

49.

McAndrew LM, Musumeci-Szabó TJ, Mora PA, Vileikyte L, Burns E, Halm EA, et al. Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. B J Health Psychol. 2008;13(2):195–204.CrossRef

50.

Scharloo M, Kaptein AA, Weinman J, Hazes JM, Willems LN, Bergman W, et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res. 1998;44(5):573–l85.CrossRefPubMed

51.

Scharloo M, Kaptein AA, Schlösser M, Pouwels H, Bel CH, Rabe KF, et al. Illness perceptions and quality of life in patients with chronic obstructive pulmonary disease. J Asthma. 2007;44(7):575–81.CrossRefPubMed

52.

Vaske I, Kenn K, Keil DC, Rief W, Stenzel NM. Illness perceptions and coping with disease in chronic obstructive pulmonary disease: effects on health-related quality of life. J Health Psychol. 2016.

53.

Zoeckler N, Kenn K, Kuehl K, Stenzel N, Rief W. Illness perceptions predict exercise capacity and psychological well-being after pulmonary rehabilitation in COPD patients. J Psychosom Res. 2014;76(2):146–51.CrossRefPubMed

54.

De Peuter S, Janssens T, Van Diest I, Stans L, Troosters T, Decramer M, et al. Dyspnea-related anxiety: the Dutch version of the breathlessness beliefs questionnaire. Chron Respir Dis. 2011;8(1):11–9.CrossRefPubMed

55.

Keil DC, Stenzel NM, Kühl K, Vaske I, Mewes R, Rief W, et al. The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis. 2014;11(1):31–40.CrossRefPubMed

56.

Janssens T, De Peuter S, Stans L, Verleden G, Troosters T, Decramer M, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest. 2011;140(3):618–25.CrossRefPubMed

57.

Heslop-Marshall K, De Soyza A. Are we missing anxiety in people with chronic obstructive pulmonary disease (COPD)? Ann Depress Anxiety. 2014;1:1023.

58.

Usmani ZA, Carson KV, Cheng JN, Esterman AJ, Smith BJ. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. The Cochrane Library. 2011.

59.

Cully JA, Paukert A, Falco J, Stanley M. Cognitive-behavioral therapy: innovations for cardiopulmonary patients with depression and anxiety. CognBehav Pract. 2009;16:394–407.

60.

Cully JA, Stanley MA, Deswal A, Hanania NA, Phillips LL, Kunik ME. Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry. 2010;12(4).

Title: Cognitive and Perceptual Factors, Not Disease Severity, Are Linked with Anxiety in COPD: Results from a Cross-Sectional Study
Authors: Elyse R. Thakur
Shubhada Sansgiry
Nancy J. Petersen
Melinda Stanley
Mark E. Kunik
Aanand D. Naik
Jeffrey A. Cully
Publication date: 01-02-2018
Publisher: Springer US
Published in: International Journal of Behavioral Medicine / Issue 1/2018
Print ISSN: 1070-5503
Electronic ISSN: 1532-7558
DOI: https://doi.org/10.1007/s12529-017-9663-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cognitive and Perceptual Factors, Not Disease Severity, Are Linked with Anxiety in COPD: Results from a Cross-Sectional Study

Abstract

Purpose

Method

Results

Conclusion

Trial Registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Method

Results

Conclusion

Trial Registration

Please log in to get access to this content

Other articles of this Issue 1/2018

Cross-Cultural Study of Information Processing Biases in Chronic Fatigue Syndrome: Comparison of Dutch and UK Chronic Fatigue Patients

Effects of a Healthy Lifestyle Education on the Incidence of Metabolic Syndrome in Children during a 13-Year Follow-up

Child Overweight and Obesity in Shanghai, China: Contextualizing Chinese Socioeconomic and Gender Differences

Mental Distress Factors and Exercise Capacity in Patients with Coronary Artery Disease Attending Cardiac Rehabilitation Program

Effectiveness of Mindfulness- and Relaxation-Based eHealth Interventions for Patients with Medical Conditions: a Systematic Review and Synthesis

Risk Compensation Following Medical Male Circumcision: Results from a 1-Year Prospective Cohort Study of Young School-Going Men in KwaZulu-Natal, South Africa